Middle East and Africa Poultry Vaccines Market Forecast to 2028

Middle East and Africa Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Broiler, Layer, and Breeder), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Others), Dosage Form (Liquid vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease [Newcastle Disease, Avian Influenza, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Salmonellosis, and Others], Route of Administration [Drinking Water (D/W) and Spray, Intramuscular (I/M), Subcutaneous (S/C), and Others], and End User (Poultry Farms and Hatcheries, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)

Report Code : BMIRE00025399 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 15/Jul/2022

The Middle East & Africa poultry vaccines market is expected to reach US$ 67.201 million by 2028 from US$ 53.162 million in 2021. The market is estimated to grow at a CAGR of 3.4% from 2021 to 2028.

The Middle East & Africa poultry vaccines market is characterized by various small and big companies. The market players are adopting the strategies such as new product launches, regional expansion, and technological advancements to increase their market share. Market players are investing in R&D to develop advanced technologies and gain more revenue share. For instance, in July 2019, CEVA SANTÉ ANIMALE Company and IDT Biologika GmbH announced their successful completion of the acquisition of IDT's veterinary biopharmaceutical as well as R&D activities by CEVA SANTÉ ANIMALE. Similarly, in 2020, Merck Poultry Vaccines signed a partnership agreement with Automazioni VX, Inc. (US). The partnership aimed to introduce Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be combined with Merck Animal Health's Innovax range of vaccines, which is used to protect against infectious poultry diseases. Further, in January 2020, Boehringer Ingelheim's and Poultry Vaccines business launched a vaccine named VAXXITEK HVT+IBD+ND to protect poultry from three diseases and provide a strong immune foundation and optimized protection against Marek's disease, infectious bursal disease (classic and variant types) and Newcastle disease. The market players are also likely to enter strategic ventures to bring in new products. For instance, in June 2018, MSD Animal Health, a Merck & Co., Inc. subsidiary, entered into a partnership agreement with Vinovo B.V. This synergistic partnership combined a broad vaccine portfolio with a novel delivery system to protect against highly infectious poultry diseases efficiently and effectively. The Middle East & Africa poultry vaccines market is expected to grow at a good CAGR during the forecast period.

Middle East & Africa Poultry Vaccines Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Poultry Vaccines Market Segmentation

The Middle East & Africa poultry vaccines market is segmented based on type, technology, dosage form, disease, route of administration, end user, and country. Based on type, the market is segmented into broiler, layer, and breeder. The breeder segment dominated the MEA poultry vaccines market in 2020. In terms of technology, the market is segmented into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines segment dominated the MEA poultry vaccines market in 2020. Based on dosage form, the market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The liquid vaccines segment dominated the MEA poultry vaccines market in 2020. Based on disease, the market is segmented into Newcastle disease, avian influenza, Marek's disease, infectious bronchitis (IB), infectious bursal disease (IBD), salmonellosis, and others. The Newcastle disease dominated the MEA poultry vaccines market in 2020. Based on route of administration, the market is segmented into drinking water (d/w) and spray, intramuscular (i/m), subcutaneous (s/c), and others. The drinking water (d/w) and spray segment dominated the MEA poultry vaccines market in 2020. Based on end user, the market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms & hatchery segment dominated the MEA poultry vaccines market in 2020. Based on country, the Middle East & Africa poultry vaccines market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa poultry vaccines market in 2020.

Boehringer Ingelheim International GmbH, Zoitis Inc., Ceya Santae Animale, BIOVAC, PHIBRO ANIMAL HEALTH CORPORATION, Hester Biosciences Limited, Dechra Pharmaceutical Plc, Elanco, and Merck Animal Health are among the leading companies in the Middle East & Africa poultry vaccines market.

Liquid vaccines Segment to Dominate Middle East & Africa Poultry Vaccines market Forecast to 2028 during 2019-2028

According to a new market research study on the Middle East & Africa Poultry Vaccines market Forecast to 2028 - by type, technology, dosage form, disease, route of administration, end user and countries is expected to reach US$ 67.201 million by 2028 from US$ 53.162 million in 2021. The market is estimated to grow at a CAGR of 3.4% from 2021 to 2028. The report provides trends prevailing in the Middle East & Africa Poultry Vaccines market along with the drivers and restraints pertaining to the market growth . Increasing prevalence of diseases in poultry is the major factor driving the growth of the Middle East & Africa Poultry Vaccines market. However, issues failure of vaccines in poultry production the growth of Middle East & Africa Poultry Vaccines market.

The Middle East & Africa Poultry Vaccines market segmented into by type, technology, dosage form, disease, route of administration, end user and countries. Based on type the Middle East & Africa Poultry Vaccines market is segmented into broiler, layer, and breeder. The breeder segment is dominated Middle East & Africa Poultry Vaccines market in 2020. Based on technology the Middle East & Africa Poultry Vaccines market segmented into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines segment Middle East & Africa Poultry Vaccines market Dominated in 2020. Based on dosage form the Middle East & Africa Poultry Vaccines market segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The liquid vaccines segment is dominated Middle East & Africa Poultry Vaccines market in 2020. Based on disease the Middle East & Africa Poultry Vaccines market segmented into newcastle disease, avian influenza, marek's disease, infectious bronchitis (ib), infectious bursal disease (ibd), salmonellosis, and others. The newcastle disease is dominated the Middle East & Africa Poultry Vaccines market in 2020. Based on route of administration the Middle East & Africa Poultry Vaccines market segmented into drinking water (d/w) and spray, intramuscular (i/m), subcutaneous (s/c) and others. The drinking water (d/w) and spray is dominated the Middle East & Africa Poultry Vaccines market in 2020. Based on end user the Middle East & Africa Poultry Vaccines market segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms & hatchery is dominated the Middle East & Africa Poultry Vaccines market in 2020. Based on country The Middle East & Africa Poultry Vaccines market segmented into South Africa, Saudi Arabia, UAE, RoMEA. The South Africa is dominated the Middle East & Africa Poultry Vaccines market in 2020.

Boehringer Ingelheim Intrnational GmbH, Zoitis Inc., Ceya Santae Animale, BIOVAC, PHIBRO ANIMAL HEALTH CORPORATION, Hester Biosciences Limited, Dechra Pharmaceutical Plc, Elanco and Merck Animal Health are among the leading companies in Middle East & Africa Poultry Vaccines market. For instance, Nov-2020 Biovac launched the local manufacturing of a six in one pediatric vaccine. Hexaxim was the first liquid 6-in-one vaccine to ever be produced, and was introduced to the South African market through the Biovac partnership with Sanofi. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in dynamic market.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Poultry Vaccines Market – By Type

1.3.2 MEA Poultry Vaccines Market – By Technology

1.3.3 MEA Poultry Vaccines Market – By Dosage Form

1.3.4 MEA Poultry Vaccines Market – By Disease

1.3.5 MEA Poultry Vaccines Market – By Route of Administration

1.3.6 MEA Poultry Vaccines Market – By End User

1.3.7 MEA Poultry Vaccines Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Poultry Vaccines Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Middle East & Africa PEST Analysis

4.3 Experts Opinion

5. MEA Poultry Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Diseases in Poultry

5.1.2 Increasing Demand for Healthy Poultry Food

5.2 Market Restraints

5.2.1 Failure of Vaccines in Poultry Production

5.3 Market Opportunities

5.3.1 Rising Growth of Market in Untapped Economies

5.4 Future Trends

5.4.1 Key Business Strategies to Enhance Market Growth in Future

5.5 Impact Analysis

6. Poultry Vaccines Market– MEA Analysis

6.1 MEA Poultry Vaccines Market Revenue Forecast and Analysis

6.1.1 Poultry Vaccines Market Revenue Forecast and Analysis

7. MEA Poultry Vaccines Market Analysis – By Type

7.1 Overview

7.2 Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)

7.3 Broiler

7.3.1 Overview

7.3.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Layer

7.4.1 Overview

7.4.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Breeder

7.5.1 Overview

7.5.2 Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Poultry Vaccines Market Analysis – By Technology

8.1 Overview

8.2 Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)

8.3 Live Attenuated Vaccines

8.3.1 Overview

8.3.2 Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Inactivated Vaccines

8.4.1 Overview

8.4.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Recombinant Vaccines

8.5.1 Overview

8.5.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Poultry Vaccines Market Analysis – By Dosage Form

9.1 Overview

9.2 Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)

9.3 Liquid Vaccines

9.3.1 Overview

9.3.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Freeze-Dried Vaccines

9.4.1 Overview

9.4.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Dust/Powdered Vaccines

9.5.1 Overview

9.5.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10. Poultry Vaccines Market Analysis – By Disease

10.1 Overview

10.2 Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)

10.3 Infectious Bronchitis

10.3.1 Overview

10.3.2 Infectious Bronchitis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Avian Influenza

10.4.1 Overview

10.4.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Marek's Disease

10.5.1 Overview

10.5.2 Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Infectious Bursal Disease

10.6.1 Overview

10.6.2 Infectious Bursal Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.7 Salmonellosis

10.7.1 Overview

10.7.2 Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.8 Newcastle Disease

10.8.1 Overview

10.8.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.9 Others

10.9.1 Overview

10.9.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11. MEA Poultry Vaccines Market Analysis – By Route of Administration

11.1 Overview

11.2 Poultry Vaccines Market Revenue Share, by Route of Administration (2021 and 2028)

11.3 Drinking water (D/W) & Spray

11.3.1 Overview

11.3.2 Drinking water (D/W) & Spray: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Intramuscular (I/M)

11.4.1 Overview

11.4.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Subcutaneous (S/C)

11.5.1 Overview

11.5.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.6 Others

11.6.1 Overview

11.6.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12. MEA Poultry Vaccines Market Analysis – By End User

12.1 Overview

12.2 Poultry Vaccines Market Share, by End User, 2021 and 2028, (%)

12.3 Veterinary Hospitals

12.3.1 Overview

12.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.4 Poultry Vaccination Centers & Clinics

12.4.1 Overview

12.4.2 Poultry Vaccination Centre: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.5 Poultry Farms and Hatchery

12.5.1 Overview

12.5.2 Poultry Farms and Hatchery: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13. MEA Poultry Vaccines Market – Country Analysis

13.1 Middle East & Africa: Poultry Vaccines Market

13.1.1 Overview

13.1.2 Middle East & Africa: Poultry Vaccines Market, by Country, 2021 & 2028 (%)

13.1.2.1 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.1.1 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.1.2 Saudi Arabia: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

13.1.2.1.3 Saudi Arabia: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

13.1.2.1.4 Saudi Arabia: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

13.1.2.1.5 Saudi Arabia: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

13.1.2.1.6 Saudi Arabia: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

13.1.2.1.7 Saudi Arabia: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

13.1.2.2 UAE: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.2.1 UAE: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.2.2 UAE: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

13.1.2.2.3 UAE: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

13.1.2.2.4 UAE: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

13.1.2.2.5 UAE: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

13.1.2.2.6 UAE: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

13.1.2.2.7 UAE: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

13.1.2.3 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.3.1 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.3.2 South Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

13.1.2.3.3 South Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

13.1.2.3.4 South Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

13.1.2.3.5 South Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

13.1.2.3.6 South Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

13.1.2.3.7 South Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

13.1.2.4 Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.4.1 Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

13.1.2.4.2 Rest of Middle East & Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

13.1.2.4.3 Rest of Middle East & Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

13.1.2.4.4 Rest of Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

13.1.2.4.5 Rest of Middle East & Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

13.1.2.4.6 Rest of Middle East & Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

13.1.2.4.7 Rest of Middle East & Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

14. Industry Landscape

14.1 Overview

14.2 Organic Developments

14.2.1 Overview

14.3 Inorganic Developments

14.3.1 Overview

15. Company Profiles

15.1 Boehringer Ingelheim International GmbH

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 Zoetis Inc.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Ceva Santé Animale

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 BIOVAC

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 PHIBRO ANIMAL HEALTH CORPORATION

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Hester Biosciences Limited

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 Dechra Pharmaceuticals PLC

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 Elanco

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 Merck Animal Health

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

16. Appendix

16.1 About the Insight Partners

16.2 Glossary of Terms

LIST OF TABLES.

Table 1. Saudi Arabia: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

Table 2. Saudi Arabia: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

Table 3. Saudi Arabia: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

Table 4. Saudi Arabia: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

Table 5. Saudi Arabia: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

Table 6. Saudi Arabia: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

Table 7. UAE: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

Table 8. UAE: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

Table 9. UAE: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

Table 10.   UAE: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

Table 11.   UAE: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

Table 12.   UAE: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

Table 13.   South Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

Table 14.   South Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

Table 15.   South Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

Table 16.   South Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

Table 17.   South Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

Table 18.   South Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

Table 19.   Rest of Middle East & Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)

Table 20.   Rest of Middle East & Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)

Table 21.   Rest of Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)

Table 22.   Rest of Middle East & Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)

Table 23.   Rest of Middle East & Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)

Table 24.   Rest of Middle East & Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)

Table 25.   Organic Developments in the Poultry Vaccine Market

Table 26.   Inorganic Developments in the Poultry Vaccine Market

Table 27.   Glossary of Terms

LIST OF FIGURES.

Figure 1. MEA Poultry Vaccines Market Segmentation

Figure 2. MEA Poultry Vaccines Market, By Country

Figure 3. MEA Poultry Vaccines Market Overview

Figure 4. Breeder Segment Held Largest Share of Type Segment in MEA Poultry Vaccines Market

Figure 5. MEA is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Middle East & Africa: PEST Analysis

Figure 7. MEA Experts Opinion

Figure 8. MEA Poultry Vaccines Market: Impact Analysis of Drivers and Restraints

Figure 9. MEA Poultry Vaccines Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.   MEA Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)

Figure 11.   MEA Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.   MEA Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.   MEA Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.   MEA Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)

Figure 15.   MEA Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.   MEA Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.   MEA Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.   MEA Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.   MEA Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)

Figure 20.   MEA Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.   MEA Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.   MEA Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.   MEA Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)

Figure 24.   MEA Infectious Bronchitis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.   MEA Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.   MEA Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.   MEA Infectious Bursal Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.   MEA Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.   MEA Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.   MEA Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.   MEA Poultry Vaccines Market Revenue Share, by Route of Administration (2021 and 2028)

Figure 32.   MEA Drinking water (D/W) & spray: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.   MEA Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.   MEA Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.   MEA Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.   MEA Poultry Vaccines Market Share, by End User, 2021 and 2028 (%)

Figure 37.   MEA Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.   MEA Poultry Vaccination Centre: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.   MEA Poultry Farms and Hatchery: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.   Middle East and Africa: Poultry Vaccines Market, by Key Country – Revenue (2021) (USD Million)

Figure 41.   Middle East & Africa: Poultry Vaccines Treatment Market, by Country, 2021 & 2028 (%)

Figure 42.   Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 43.   UAE: Poultry Vaccines Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 44.   South Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 45.   Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - Middle East and Africa Poultry Vaccines Market

● Boehringer Ingelheim Intrnational GmbH.

● Zoitis Inc.

● Ceya Santae Animale.

● BIOVAC.

● PHIBRO ANIMAL HEALTH CORPORATION.

● Hester Biosciences Limited.

● Dechra Pharmaceutical Plc.

● Elanco.

● Merck Animal Health.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Poultry Vaccines market forecast.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa Poultry Vaccines market forecast, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the poultry vaccines market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TOP